Insiders Buying Into the Huge Rallies in Evolus (EOLS), Verastem (VSTM)
Insiders are masters of snatching up shares of their companies at a discount, expanding their positions during weakness in the stock.
Posts Tagged ‘Novartis AG (ADR) (NVS)’
30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
10 Most Profitable Companies In Europe
Out of the 10 companies on this list, four are from Switzerland, while three are from Germany, reflective of the favorable position of the two countries in Europe’s economic...
10 Most Advanced Technologies In The World Today
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition
After recently getting the approval of the U.S.
Positive Results For AbbVie Inc (ABBV) Humira Biosimilar Reported By Novartis AG (ADR) (NVS)
A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira biosimilar.
Novartis AG (ADR) (NVS) Fined And Some Products To Be Temporarily Suspended In South Korea
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend...
Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Novartis AG (ADR) (NVS) Greater Use Of Technology In Transforming Medical Education
Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology.
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus Pharmaceuticals Inc (CNAT)
Novartis AG (ADR) (NYSE:NVS) and Conatus Pharmaceuticals Inc (NASDAQ:CNAT) will jointly develop Conatus drug emricasan.
Novartis AG (ADR) (NVS) Acquires Selexys Pharmaceuticals Corp.
Novartis AG (ADR) (NYSE:NVS) has recently acquired Selexys Pharmaceuticals Corp.
5 Healthcare Stocks Kahn Brothers Is Bullish On
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer
Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)'s Ibrance.
Here’s What’s Important With The Novartis AG (ADR) (NVS) MS Data
Novartis AG (ADR) (NYSE:NVS) just put out data from its multiple sclerosis (MS) trial, and it looks as if the company is winning the race to bring a drug to market that offers...
Billionaire Jim Simons’ Top High-Dividend Stock Picks
Most individual investors invest in dividend-paying stocks to benefit from the steady streams of dividend checks, but can also take advantage of stock price appreciation as...
Chiasma Inc (CHMA)’s Shares Jump 35% On First Day Of Trading
The shares of Chiasma Inc (NASDAQ:CHMA) are up by 25% on its first day of trading at $20.02 per share as of the time of writing.
BioScrip Inc (BIOS): GAMCO Investors Still Bullish and Buys More Shares
GAMCO Investors and other funds managed by Mario Gabelli continue to aggressively add to their holdings in BioScrip Inc (NASDAQ:BIOS), having increased their position by another...
International Business Machines Corp. (IBM) and Google Inc (GOOGL): Hank Smith Love These Stocks
In a discussion with Fox Business News anchors David Asman and Liz Claman from the show ‘After the bell,’ Hank Smith, who is the CIO of Haverford, speaks on his stock picks...
Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals
In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr.
Foreign Companies News: Rio Tinto plc (ADR) (RIO), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK)
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)’s Buyout Radar
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.
Johnson & Johnson (JNJ): New Drugs and Better Manufacturing Make This Stock a Buy
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Hedge Funds Are Betting On Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): These 2 Healthcare Stocks Could Win Big With FDA’s New ‘Breakthrough’ Status
The Food and Drug Administration (FDA) made a groundbreaking policy change last year that is having a large impact on the biotech industry and creating a big opportunity for...
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
Novartis AG (ADR) (NVS): Are Hedge Funds Right About This Stock?
Novartis AG (ADR) (NYSE:NVS) was in 24 hedge funds' portfolio at the end of March.
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS), Pfizer Inc. (PFE): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
Biogen Idec Inc. (BIIB) Bounces Higher
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Do Hedge Funds and Insiders Love Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Does Novartis AG (ADR) (NVS)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, looking for current income have been forced to move away from fixed-income positions and into stocks to find yield.
